Aortic valve replacement in a young patient with essential thrombocytosis

[1]  J. van der Linden,et al.  Aprotinin Decreases Postoperative Bleeding and Number of Transfusions in Patients on Clopidogrel Undergoing Coronary Artery Bypass Graft Surgery: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial , 2005, Circulation.

[2]  J. Michiels,et al.  Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: Relationship with platelet count , 1994, Annals of Hematology.

[3]  P. Epstein,et al.  Hämorrhagische Thrombocythämie bei vasculärer Schrumpfmilz , 1934, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin.

[4]  T. Barbui,et al.  Treatment indications and choice of a platelet-lowering agent in essential thrombocythemia. , 2003, Current hematology reports.

[5]  J. Bradfield,et al.  Aprotinin restores the adhesive capacity of dysfunctional platelets. , 2003, Thrombosis research.

[6]  E. Ikkala,et al.  The predictive value of vascular risk factors and gender for the development of thrombotic complications in essential thrombocythemia , 2001, Annals of Hematology.

[7]  R. Labow,et al.  Hematologic evaluation of cardiopulmonary bypass circuits prepared with a novel block copolymer. , 1999, The Annals of thoracic surgery.

[8]  C. Harrison,et al.  A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. , 1999, Blood.

[9]  E. Topol,et al.  Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. , 1995, The New England journal of medicine.

[10]  S. Capitani,et al.  Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet‐derived transforming growth factor β1, produced in normal amount, in patients with essential thrombocythaemia , 1993, British journal of haematology.

[11]  W. van Oeveren,et al.  Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. , 1993, The Journal of thoracic and cardiovascular surgery.

[12]  Arturo Pereira,et al.  Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients. , 1991, Acta haematologica.

[13]  J. George,et al.  Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. , 1986, The Journal of clinical investigation.